Faculty

Dr. Widge collaborated with Massachusetts General Hospital to develop algorithms to track patients’ cognitive control abilities for epileptic patients after brain surgery. 

Dr. Anna Wirta Kosobuski and her research team released the final materials in the series of four activity books addressing youth nutrition and wellness titled in Ojibwe, “Minwanjige, Mino Bimaadizi (Eat Well, Live Well).”

Medical School and the College of Biological Sciences have received $8.5 million over five years to expand on their work studying non-dividing cells that increase with age

The Udall Center at the University of Minnesota Medical School was awarded a new $11.3 million grant from the National Institute for Neurological Disorders and Stroke to continue its work in deep brain stimulation (DBS) for Parkinson’s disease.

MN-SCIMS, led by the Dr. Leslie Morse, will be an interdisciplinary team in the upper Midwest to expand research and inform clinical care on spinal cord injuries. 

Recent studies may point towards a new therapeutic mechanism for a type of heart failure that currently has no specific treatment option. Researchers from the University of Minnesota Medical School — along with the University of Vermont and the Medical University of South Carolina — looked into a condition called heart failure with a preserved ejection fraction, or HFpEF. They discovered this mechanism that could prove useful in this common, yet hard-to-treat, condition.

The Intro to Rural Family Medicine and Native American Health (IRFMNAH) course is a collaborative academic experience where students get real-life training that introduces both rural medicine and Native American health. 

In 2018, the Fond du Lac Band of Lake Superior Chippewa published a health impact assessment that described the important role of manoomin—wild rice—to support the health of tribal members. In response to the findings, Emily Onello, MD, and fellow U of M Researchers are joining the scientific study.

Please join us on Tuesday, Oct. 26 for this month’s seminar, focusing on the high risk of depression comorbidity among women with substance use disorders. Presented by Dr. Marta Torrens of the Institute of Neuropsychiatry and Addictions Hospital del Mar in Barcelona, Spain.

In a first-of-its-kind study, researchers from the University of Minnesota Medical School led a large, multicenter investigation on whether cardiovascular magnetic resonance (CMR) is the best approach in evaluating patients with suspected cardiac tumors. Their results prove that CMR provides high accuracy and prognostic value for this purpose.

Pages